New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
10:00 EDTSIRI, PRU, SD, UNP, TEVA, QSII, GTAT, IVN, CLH, CHTR, BMO, TFM, SKUL, PLCM, CCRN, COG, UCBI, HAE, BPI, BKE, SWY, OCR, CPAOn The Fly: Analyst Upgrade Summary
Copa Holdings (CPA) upgraded to Buy from Neutral at UBS... Cross Country Healthcare (CCRN) upgraded to Buy from Neutral at Citigroup... GT Advanced (GTAT) upgraded to Outperform from Neutral at Credit Suisse... Omnicare (OCR) upgraded to Buy from Neutral at UBS... Polycom (PLCM) upgraded to Buy from Neutral at Citigroup... Quality Systems (QSII) upgraded to Market Perform from Underperform at FBR Capital... Safeway (SWY) upgraded to Neutral from Sell at UBS... Skullcandy (SKUL) upgraded to Outperform from Market Perform at Northland Securities... Teva (TEVA) upgraded to Overweight from Equal Weight at Barclays... The Buckle (BKE) upgraded to Neutral from Sell at Janney Capital... The Fresh Market (TFM) upgraded to Buy from Neutral at UBS... Union Pacific (UNP) upgraded to Outperform from Market Perform at Avondale... Bridgepoint Education (BPI) upgraded to Outperform at William Blair... Bank of Montreal (BMO) upgraded to Sector Performer from Underperformer at CIBC... SandRidge Energy (SD) upgraded to Overweight at Stephens citing turnaround progress... Haemonetics (HAE) upgraded to Buy from Neutral at Sidoti... Charter (CHTR) upgraded at Northland Securities... Prudential (PRU) upgraded to Buy from Neutral at BofA/Merrill... United Community Banks (UCBI) upgraded to Buy from Hold at Sandler O'Neill... Sirius XM (SIRI) upgraded at Macquarie... Clean Harbors (CLH) upgraded at Raymond James... Cabot Oil & Gas (COG) upgraded to Buy from Accumulate at KLR Group... Ivanhoe Mines (IVN) upgraded to Buy from Neutral at UBS.
News For CPA;CCRN;GTAT;OCR;PLCM;QSII;SWY;SKUL;TEVA;BKE;TFM;UNP;BPI;BMO;SD;HAE;CHTR;PRU;UCBI;CLH;SIRI;COG;IVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
December 11, 2014
07:12 EDTTEVATeva sees FY15 Copaxone sales $3.5B-$3.7B
Sees FY15 Treanda sales $670M-$750M. Sees FY15 ProAir family sales $470M-$580M, Azilect sales $350M-$400M and Nuvigil sales $300M-$330M. Erez Vigodman, President & CEO of Teva, said, "Generics remain at the heart of our business, both as the cornerstone of the Company, but also as an area that has great impact on society. At the same time, we anticipate four specialty product approvals and five submissions in 2015 – which we believe will improve treatment options for patients, and add value for all of our stakeholders." The company expects 2015 generic revenues in the United States to be $4.2B-$4.6B, $2.6B-$3.0B in Europe and $2.0B-$2.3B in its ROW markets. Results of its specialty segment are expected to be impacted by the introduction of two AB-rated generic competitors to Copaxone in the U.S. beginning in September 2015, which is a modeling assumption only, as well as by increased competition from oral products for the treatment of multiple sclerosis. In addition, the company is expecting to invest in a significant number of product launches and in its specialty pipeline. "All of these will result in lower profit and profitability, as we focus on generating growth over the next few years," Teva said.
07:08 EDTTEVATeva sees FY15 gross profit 59.5%-61.5%
Teva sees FY15 cash flow from operations $4.3B-$4.7B and free cash flow $3.5B-$3.7B.
07:07 EDTTEVATeva sees spending $1B-$1.2B on share buybacks in 2015
Subscribe for More Information
07:02 EDTTEVATeva sees FY15 EPS $5.00-$5.30, consensus $5.06
Sees FY15 revenue $19B-$19.4B, consensus $20.07B.
December 10, 2014
10:00 EDTUNPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with an Underperform at Longbow... AutoZone (AZO) initiated with a Buy at Nomura... C.H. Robinson (CHRW) initiated with a Neutral at Nomura... CSX (CSX) initiated with a Buy at Nomura... CVS Health (CVS) initiated with a Neutral at Citigroup... Canadian National (CNI) initiated with a Neutral at Nomura... Carrizo Oil & Gas (CRZO) initiated with a Buy at Canaccord... CenterPoint Energy (CNP) initiated with a Neutral at Nomura... Con-way (CNW) initiated with a Neutral at Nomura... Cornerstone OnDemand (CSOD) initiated with a Buy at BofA/Merrill... Depomed (DEPO) initiated with an Outperform at RBC Capital... Dollar General (DG) initiated with a Buy at Citigroup... Dollar Tree (DLTR) initiated with a Neutral at Citigroup... Dynagas LNG (DLNG) initiated with a Buy at ABN Amro... EMC (EMC) initiated with a Neutral at JPMorgan... Energy Focus (EFOI) initiated with a Buy at Roth Capital... Expeditors (EXPD) initiated with a Neutral at Nomura... GasLog (GLOG) initiated with a Buy at ABN Amro... Genesee & Wyoming (GWR) initiated with a Neutral at Nomura... Golar LNG (GLNG) initiated with a Sell at ABN Amro... HII Technologies (HIIT) initiated with a Buy at Roth Capital... Hudbay Minerals (HBM) initiated with an Overweight at Barclays... J.B. Hunt (JBHT) initiated with a Buy at Nomura... Kansas City Southern (KSU) initiated with a Buy at Nomura... Kroger (KR) initiated with a Buy at Citigroup... Lear (LEA) initiated with a Buy at Northcoast... Lundin Mining (LUNMF) initiated with an Overweight at Barclays... NetApp (NTAP) initiated with a Neutral at JPMorgan... Norfolk Southern (NSC) initiated with a Neutral at Nomura... PROS (PRO) initiated with an Outperform at Pacific Crest... Qlik Technologies (QLIK)initiated with a Buy at BofA/Merrill... Rentokil (RTOKY) initiated with a Neutral at UBS... Revolution Lighting (RVLT) initiated with a Buy at Roth Capital... ServiceNow (NOW) initiated with a Buy at BofA/Merrill... Stratasys (SSYS) initiated with a Neutral at Longbow... Suburban Propane (SPH) initiated with a Hold at Stifel... Tableau (DATA) initiated with a Buy at BofA/Merrill... Teekay LNG (TGP) initiated with a Buy at ABN Amro... Tessera (TSRA) initiated with a Buy at Sidoti... Union Pacific (UNP) initiated with a Buy at Nomura... Viper Energy (VNOM) initiated with a Buy at Stifel... Visteon (VC) initiated with a Buy at Northcoast... Walgreen (WAG) initiated with a Buy at Citigroup... Werner (WERN) initiated with a Neutral at Nomura.
08:31 EDTTEVATeva announces launch of first generic Celebrex capsules in the U.S.
Teva Pharmaceutical Industries (TEVA) announces the launch of the first FDA-approved generic equivalent to Celebrex Capsules in the United States. Teva is offering 50, 100, 200, and 400 mg strengths of Celecoxib Capsules. Celebrex Capsules, marketed by Pfizer (PFE) had annual sales of approximately $2.56B in the United States, according to IMS data as of October 2014.
08:18 EDTTFMDeutsche Bank to hold a conference
Subscribe for More Information
06:37 EDTUNPUnion Pacific initiated with a Buy at Nomura
Subscribe for More Information
December 9, 2014
17:33 EDTCCRNCross Country Healthcare files to sell 3.52M shares of common stock for holders
14:51 EDTSKULSkullcandy management to meet with Piper Jaffray
Subscribe for More Information
07:44 EDTTEVAAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
07:44 EDTOCROmnicare management to meet with UBS
Meeting to be held in San Francisco on December 9 hosted by UBS.
07:06 EDTBKEThe Buckle announces special cash dividend, increased quarterly dividend
The Buckle, Inc. announced that at its quarterly meeting of the Board of Directors, held on December 8, the Board authorized a $2.77 per share special cash dividend to be paid to shareholders of record at the close of business on January 15, 2015. The Board also authorized a 23c per share quarterly dividend to be paid to shareholders of record at the close of business on January 15, 2015. This represents an increase of 1c per share, or 4.5%, in the company’s regular quarterly dividend rate. Both the $2.77 per share special cash dividend and the 23c per share regular quarterly dividend are payable on January 27, 2015 and will be paid together.
07:01 EDTCOGCabot Oil & Gas coverage resumed with a Hold at Stifel
Subscribe for More Information
05:55 EDTSIRIStocks with implied volatility movement; CME SIRI
Subscribe for More Information
December 8, 2014
14:20 EDTPRUPrudential to host conference call
Subscribe for More Information
11:30 EDTTEVALeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
08:21 EDTPRUSL Green Realty, Prudential Real Estate Investors form JV
Subscribe for More Information
08:21 EDTTEVAMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
06:47 EDTTEVAArena says Teva files marketing authorization of Belviq in Israel
Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use